Oral valganciclovir initiated beyond one month of age as treatment of sensorineural hearing loss caused by congenital cytomegalovirus infection: A Randomized Clinical Trial

Authors
Publication date
Publisher
Elsevier Inc.

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Newcastle University E-Prints

    redirect
    oaioai:eprints.ncl.ac.uk:296432
    Last time updated on 05/02/2024